P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease

Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, with no increased risk of major bleeding, finds a study published by The BMJ…